Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cardiovascular Diseases × Genetic Testing × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Prostatic Neoplasms 9 Colorectal Neoplasms 6 Endometrial Neoplasms 5 Ovarian Neoplasms 4 Colonic Neoplasms 4 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Leukemia, Myeloid, Acute 3 Colorectal Neoplasms, Hereditary Nonpolyposis 3 Brain Neoplasms 3 Urogenital Neoplasms 2 Neoplastic Syndromes, Hereditary 2 Neoplasms, Unknown Primary 2 Neoplasm Metastasis 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Leukemia, Eosinophilic, Acute 2 Leukemia, Basophilic, Acute 2 Leukemia 2 Hereditary Breast and Ovarian Cancer Syndrome 2 Hematologic Neoplasms 2 Glioma 2 Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8 1 Tuberous Sclerosis 1 Thyroid Neoplasms 1 Spinal Cord Neoplasms 1 Sarcoma 1

Interventions

Exercise 4 Cholecalciferol 4 Gonadotropin-Releasing Hormone 3 Blood Pressure 3 Atorvastatin 3 palbociclib 2 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2 acalabrutinib 2 Vitamin E 2 Social Determinants of Health 2 Rosuvastatin Calcium 2 Nutrition Assessment 2 Metformin 2 Geritol 2 Fish Oils 2 Fatty Acids, Omega-3 2 Ethanol 2 Educational Status 2 Diet, Mediterranean 2 Blood Specimen Collection 2 Aspirin 2 Absorptiometry, Photon 2 zanubrutinib 1 xinmailong 1 ribociclib 1 phosphoribosylformylglycinamidine synthetase 1 pembrolizumab 1 ibrutinib 1 glycidol 1 beta Carotene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02485626 2016-10-31

HARBOR

The Netherlands Cancer Institute

Breast Neoplasms, Cardiovascular Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡